• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

涉及多巴胺能神经传递的遗传多态性与日本人群帕金森病的风险。

Genetic polymorphisms involved in dopaminergic neurotransmission and risk for Parkinson's disease in a Japanese population.

机构信息

Department of Preventive Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

出版信息

BMC Neurol. 2011 Jul 25;11:89. doi: 10.1186/1471-2377-11-89.

DOI:10.1186/1471-2377-11-89
PMID:21781348
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3199768/
Abstract

BACKGROUND

Parkinson's disease (PD) is characterized by alterations in dopaminergic neurotransmission. Genetic polymorphisms involved in dopaminergic neurotransmission may influence susceptibility to PD.

METHODS

We investigated the relationship of catechol-O-methyltransferase (COMT), monoamine oxidase B (MAOB), dopamine receptor (DR) D2 and DRD4 polymorphisms and PD risk with special attention to the interaction with cigarette smoking among 238 patients with PD and 369 controls in a Japanese population.

RESULTS

Subjects with the AA genotype of MAOB rs1799836 showed a significantly increased risk of PD (odds ratio (OR) = 1.70, 95% confidence interval (CI) = 1.12 - 2.58) compared with the AG and GG genotypes combined. The AA genotype of COMT rs4680 was marginally associated with an increased risk of PD (OR = 1.86, 95% CI = 0.98 - 3.50) compared with the GG genotype. The DRD2 rs1800497 and DRD4 rs1800955 polymorphisms showed no association with PD. A COMT -smoking interaction was suggested, with the combined GA and AA genotypes of rs4680 and non-smoking conferring significantly higher risk (OR = 3.97, 95% CI = 2.13 - 7.41) than the AA genotype and a history of smoking (P for interaction = 0.061). No interactions of smoking with other polymorphisms were observed.

CONCLUSIONS

The COMT rs4680 and MAOB rs1799836 polymorphisms may increase susceptibility to PD risk among Japanese. Future studies involving larger control and case populations and better pesticide exposure histories will undoubtedly lead to a more thorough understanding of the role of the polymorphisms involved in the dopamine pathway in PD.

摘要

背景

帕金森病(PD)的特征是多巴胺能神经传递的改变。参与多巴胺能神经传递的遗传多态性可能影响 PD 的易感性。

方法

我们研究了儿茶酚-O-甲基转移酶(COMT)、单胺氧化酶 B(MAOB)、多巴胺受体(DR)D2 和 DRD4 多态性与 PD 风险的关系,并特别关注日本人群中 238 例 PD 患者和 369 例对照者中与吸烟的相互作用。

结果

与 AG 和 GG 基因型组合相比,MAOB rs1799836 的 AA 基因型的个体患 PD 的风险显著增加(比值比(OR)=1.70,95%置信区间(CI)=1.12-2.58)。与 GG 基因型相比,COMT rs4680 的 AA 基因型与 PD 风险略有增加(OR=1.86,95%CI=0.98-3.50)。DRD2 rs1800497 和 DRD4 rs1800955 多态性与 PD 无关。提示 COMT-吸烟相互作用,rs4680 的 GA 和 AA 基因型与非吸烟相结合可显著增加风险(OR=3.97,95%CI=2.13-7.41),高于 AA 基因型和吸烟史(P 交互=0.061)。未观察到吸烟与其他多态性之间的相互作用。

结论

COMT rs4680 和 MAOB rs1799836 多态性可能会增加日本人群患 PD 风险。未来涉及更大的对照和病例人群以及更好的农药暴露史的研究无疑将导致更深入地了解多巴胺通路中涉及的多态性在 PD 中的作用。

相似文献

1
Genetic polymorphisms involved in dopaminergic neurotransmission and risk for Parkinson's disease in a Japanese population.涉及多巴胺能神经传递的遗传多态性与日本人群帕金森病的风险。
BMC Neurol. 2011 Jul 25;11:89. doi: 10.1186/1471-2377-11-89.
2
Association of monoamine oxidase B and catechol-O-methyltransferase polymorphisms with sporadic Parkinson's disease in an Iranian population.单胺氧化酶 B 和儿茶酚-O-甲基转移酶多态性与伊朗人群散发性帕金森病的关联。
Folia Neuropathol. 2012;50(4):382-9. doi: 10.5114/fn.2012.32368.
3
A meta-analysis on relationship of MAOB intron 13 polymorphisms, interactions with smoking/COMT H158L polymorphisms with the risk of PD.一项关于单胺氧化酶B基因内含子13多态性、与吸烟/儿茶酚-O-甲基转移酶H158L多态性的相互作用与帕金森病风险关系的荟萃分析。
Int J Neurosci. 2016;126(5):400-7. doi: 10.3109/00207454.2015.1028057. Epub 2015 Jul 20.
4
Impact of COMT H108L, MAOB int 13 A>G and DRD2 haplotype on the susceptibility to Parkinson's disease in South Indian subjects.儿茶酚-O-甲基转移酶H108L、单胺氧化酶B内含子13 A>G及多巴胺D2受体单倍型对南印度人群帕金森病易感性的影响
Indian J Biochem Biophys. 2013 Oct;50(5):436-41.
5
[Polymorphisms of catechol-O-methyltransferase and monoamine oxidase B genes among Chinese patients with Parkinson's disease].[中国帕金森病患者儿茶酚-O-甲基转移酶和单胺氧化酶B基因的多态性]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2015 Feb;32(1):1-5. doi: 10.3760/cma.j.issn.1003-9406.2015.01.001.
6
MAOB intron 13 and COMT codon 158 polymorphisms, cigarette smoking, and the risk of PD.单胺氧化酶B基因内含子13和儿茶酚-O-甲基转移酶基因第158位密码子多态性、吸烟与帕金森病风险
Neurology. 2002 May 14;58(9):1381-7. doi: 10.1212/wnl.58.9.1381.
7
Association study of functional polymorphisms of dopaminergic pathway in epilepsy-related factors of temporal lobe epilepsy in Brazilian population.巴西人群中多巴胺能通路功能多态性与颞叶癫痫相关因素的关联研究。
Eur J Neurol. 2018 Jun;25(6):895-901. doi: 10.1111/ene.13631. Epub 2018 Apr 10.
8
Association of COMT rs4680 and MAO-B rs1799836 polymorphisms with levodopa-induced dyskinesia in Parkinson's disease-a meta-analysis.COMT rs4680 和 MAO-B rs1799836 多态性与帕金森病患者左旋多巴诱导的运动障碍的关联:一项荟萃分析。
Neurol Sci. 2021 Oct;42(10):4085-4094. doi: 10.1007/s10072-021-05509-3. Epub 2021 Aug 4.
9
Epistatic effect of Ankyrin repeat and kinase domain containing 1 - Dopamine receptor D2 and catechol-o-methyltransferase single nucleotide polymorphisms on the risk for hazardous use of alcohol in Lithuanian population.ANKRD1 与激酶结构域包含蛋白 1-多巴胺受体 D2 和儿茶酚-O-甲基转移酶单核苷酸多态性的上位效应与立陶宛人群酒精使用障碍易感性的关系。
Gene. 2021 Jan 10;765:145107. doi: 10.1016/j.gene.2020.145107. Epub 2020 Sep 2.
10
Association of Catechol-O-Methyltransferase and monoamine oxidase B gene polymorphisms with motor complications in parkinson's disease in a Chinese population.中国人群中儿茶酚-O-甲基转移酶和单胺氧化酶B基因多态性与帕金森病运动并发症的关联
Parkinsonism Relat Disord. 2014 Oct;20(10):1041-5. doi: 10.1016/j.parkreldis.2014.06.021. Epub 2014 Jul 4.

引用本文的文献

1
Type A monoamine oxidase; its unique role in mood, behavior and neurodegeneration.A型单胺氧化酶;其在情绪、行为和神经退行性变中的独特作用。
J Neural Transm (Vienna). 2025 Mar;132(3):387-406. doi: 10.1007/s00702-024-02866-z. Epub 2024 Dec 2.
2
Polymorphism Associated with Progression in a Chinese Parkinson's Disease Cohort but Not in the PPMI Cohort.在中国帕金森病队列中与疾病进展相关的多态性,但在PPMI队列中并非如此。
Parkinsons Dis. 2022 Sep 17;2022:3481102. doi: 10.1155/2022/3481102. eCollection 2022.
3
Environmental Impact on the Epigenetic Mechanisms Underlying Parkinson's Disease Pathogenesis: A Narrative Review.环境对帕金森病发病机制潜在表观遗传机制的影响:一篇叙述性综述
Brain Sci. 2022 Jan 28;12(2):175. doi: 10.3390/brainsci12020175.
4
The Role of Single Nucleotide Polymorphisms of Monoamine Oxidase B, Dopamine D2 Receptor, and DOPA Decarboxylase Receptors Among Patients Treated for Parkinson's Disease.单胺氧化酶 B、多巴胺 D2 受体和多巴脱羧酶受体的单核苷酸多态性在帕金森病患者治疗中的作用。
J Mol Neurosci. 2022 Apr;72(4):812-819. doi: 10.1007/s12031-022-01966-3. Epub 2022 Jan 19.
5
Polymorphisms of Dopamine Receptor Genes and Parkinson's Disease: Clinical Relevance and Future Perspectives.多巴胺受体基因多态性与帕金森病:临床相关性及未来展望。
Int J Mol Sci. 2021 Apr 6;22(7):3781. doi: 10.3390/ijms22073781.
6
The Gene Polymorphism of VMAT2 Is Associated with Risk of Schizophrenia in Male Han Chinese.VMAT2基因多态性与汉族男性精神分裂症风险相关。
Psychiatry Investig. 2020 Nov;17(11):1073-1078. doi: 10.30773/pi.2020.0023. Epub 2020 Oct 27.
7
Monoamine oxidase B rs1799836 G allele polymorphism is a risk factor for early development of levodopa-induced dyskinesia in Parkinson's disease.单胺氧化酶B rs1799836 G等位基因多态性是帕金森病中左旋多巴诱导的异动症早期发生的一个危险因素。
eNeurologicalSci. 2020 Apr 6;19:100239. doi: 10.1016/j.ensci.2020.100239. eCollection 2020 Jun.
8
Gene polymorphisms and motor levodopa-induced complications in Parkinson's disease.基因多态性与帕金森病运动性左旋多巴诱导并发症。
Brain Behav. 2020 Mar;10(3):e01537. doi: 10.1002/brb3.1537. Epub 2020 Feb 5.
9
Association between dopamine receptor D2 TaqIA polymorphism and Parkinson disease risk: a meta-analysis.多巴胺受体D2 TaqIA基因多态性与帕金森病风险的关联:一项荟萃分析。
Int J Clin Exp Pathol. 2019 Sep 1;12(9):3165-3170. eCollection 2019.
10
Association between the DRD2 TaqIA gene polymorphism and Parkinson disease risk: an updated meta-analysis.DRD2 TaqIA基因多态性与帕金森病风险之间的关联:一项更新的荟萃分析。
Medicine (Baltimore). 2019 Sep;98(37):e17136. doi: 10.1097/MD.0000000000017136.

本文引用的文献

1
Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database.帕金森病遗传学的综合研究综述和系统荟萃分析:PDGene 数据库。
PLoS Genet. 2012;8(3):e1002548. doi: 10.1371/journal.pgen.1002548. Epub 2012 Mar 15.
2
Smoking, genes encoding dopamine pathway and risk for Parkinson's disease.吸烟、多巴胺通路基因与帕金森病风险。
Neurosci Lett. 2010 Sep 20;482(1):31-4. doi: 10.1016/j.neulet.2010.06.085. Epub 2010 Jul 14.
3
A case-control study of Parkinson's disease and tobacco use: gene-tobacco interactions.帕金森病与吸烟的病例对照研究:基因-烟草相互作用。
Mov Disord. 2010 May 15;25(7):912-9. doi: 10.1002/mds.22980.
4
No association of the Val158Met COMT polymorphism with Parkinson's disease in the Greek population.在希腊人群中,儿茶酚-O-甲基转移酶(COMT)基因Val158Met多态性与帕金森病无关联。
Eur J Neurol. 2008 Aug;15(8):e83. doi: 10.1111/j.1468-1331.2008.02186.x.
5
Comment on "Genetically determined differences in learning from errors".关于《基因决定的从错误中学习的差异》的评论
Science. 2008 Jul 11;321(5886):200; author reply 200. doi: 10.1126/science.1156079.
6
Polymorphism in environment responsive genes and association with Parkinson disease.环境响应基因的多态性及其与帕金森病的关联。
Mol Cell Biochem. 2008 May;312(1-2):131-8. doi: 10.1007/s11010-008-9728-2. Epub 2008 Mar 9.
7
Epidemiology of Parkinson's disease.帕金森病的流行病学
Lancet Neurol. 2006 Jun;5(6):525-35. doi: 10.1016/S1474-4422(06)70471-9.
8
An abnormal mRNA produced by a novel PMP22 splice site mutation associated with HNPP.一种由与遗传性压力易感性周围神经病(HNPP)相关的新型外周髓鞘蛋白22(PMP22)剪接位点突变产生的异常信使核糖核酸(mRNA) 。
J Neurol Neurosurg Psychiatry. 2006 Apr;77(4):538-40. doi: 10.1136/jnnp.2005.075242. Epub 2005 Sep 30.
9
A G-to-A transition at the fifth position of intron-32 of the dystrophin gene inactivates a splice-donor site both in vivo and in vitro.肌营养不良蛋白基因第32号内含子第5位的G到A转换在体内和体外均使一个剪接供体位点失活。
Mol Genet Metab. 2005 Jul;85(3):213-9. doi: 10.1016/j.ymgme.2005.03.006.
10
Catechol-O-methyltransferase and monoamine oxidase B genes and susceptibility to sporadic Parkinson's disease in a Polish population.儿茶酚-O-甲基转移酶和单胺氧化酶B基因与波兰人群散发性帕金森病易感性
Eur Neurol. 2005;53(2):68-73. doi: 10.1159/000084302. Epub 2005 Mar 7.